Abstract
1 Direct myocardial effects of the S(-)- and R(+)-enantiomers of bupivacaine were compared in the guinea-pig isolated papillary muscle by recording transmembrane action potentials with the standard microelectrode technique. 2 In 5.4 mM K+, at a stimulation rate of 1 Hz, the maximal rate of depolarization (Vmax) was reduced to 59.9 +/- 1.4% (n = 10) of control (mean +/- s.e.mean) in the presence of 10 microM R(+)-bupivacaine, and to 76.7 +/- 1.2% (n = 14) in the presence of the same concentration of S(-)-bupivacaine. This was mainly due to a difference in time constant at which block dissipated during the diastolic period. Recovery was slower in the presence of R(+)-bupivacaine. The slower recovery in the presence of R(+)-bupivacaine resulted also in a more pronounced frequency-dependent block of Vmax. 3 Time constants for recovery from use-dependent block became significantly faster for both enantiomers on hyperpolarization, while no significant change was observed at depolarization. At all membrane potentials recovery was slower in the presence of R(+)-bupivacaine. 4 The action potential duration (APD) was shortened to a greater extent in the presence of R(+)-bupivacaine over a large range of stimulation frequencies. 5 We conclude that S(-)-bupivacaine affects Vmax and APD in the guinea-pig papillary muscle less than the R(+)-enantiomer at different rates of stimulation and resting membrane potentials.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol (Copenh) 1972;31(4):273–286. [PubMed] [Google Scholar]
- Albright G. A. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979 Oct;51(4):285–287. doi: 10.1097/00000542-197910000-00001. [DOI] [PubMed] [Google Scholar]
- Aps C., Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol. 1978 Jul;6(1):63–68. doi: 10.1111/j.1365-2125.1978.tb01683.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bean B. P., Cohen C. J., Tsien R. W. Lidocaine block of cardiac sodium channels. J Gen Physiol. 1983 May;81(5):613–642. doi: 10.1085/jgp.81.5.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Block A. J., Merrill D., Smith E. R. Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro. J Cardiovasc Pharmacol. 1988 Feb;11(2):216–221. [PubMed] [Google Scholar]
- Buffington C. W. The magnitude and duration of direct myocardial depression following intracoronary local anesthetics: a comparison of lidocaine and bupivacaine. Anesthesiology. 1989 Feb;70(2):280–287. doi: 10.1097/00000542-198902000-00017. [DOI] [PubMed] [Google Scholar]
- Carmeliet E., Saikawa T. Shortening of the action potential and reduction of pacemaker activity by lidocaine, quinidine, and procainamide in sheep cardiac purkinje fibers. An effect on Na or K currents? Circ Res. 1982 Feb;50(2):257–272. doi: 10.1161/01.res.50.2.257. [DOI] [PubMed] [Google Scholar]
- Clarkson C. W., Hondeghem L. M. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology. 1985 Apr;62(4):396–405. [PubMed] [Google Scholar]
- Covino B. G. Recent advances in local anaesthesia. Can Anaesth Soc J. 1986 May;33(3 Pt 2):S5–S8. doi: 10.1007/BF03019149. [DOI] [PubMed] [Google Scholar]
- Hill R. J., Duff H. J., Sheldon R. S. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. Mol Pharmacol. 1988 Nov;34(5):659–663. [PubMed] [Google Scholar]
- Hotvedt R., Platou E. S., Refsum H. Electrophysiological effects of thoracic epidural analgesia in the dog heart in situ. Cardiovasc Res. 1983 May;17(5):259–266. doi: 10.1093/cvr/17.5.259. [DOI] [PubMed] [Google Scholar]
- Hotvedt R., Refsum H., Helgesen K. G. Cardiac electrophysiologic and hemodynamic effects related to plasma levels of bupivacaine in the dog. Anesth Analg. 1985 Apr;64(4):388–394. [PubMed] [Google Scholar]
- Komai H., Rusy B. F. Effects of bupivacaine and lidocaine on AV conduction in the isolated rat heart: modification by hyperkalemia. Anesthesiology. 1981 Sep;55(3):281–285. doi: 10.1097/00000542-198109000-00017. [DOI] [PubMed] [Google Scholar]
- Kotelko D. M., Shnider S. M., Dailey P. A., Brizgys R. V., Levinson G., Shapiro W. A., Koike M., Rosen M. A. Bupivacaine-induced cardiac arrhythmias in sheep. Anesthesiology. 1984 Jan;60(1):10–18. doi: 10.1097/00000542-198401000-00004. [DOI] [PubMed] [Google Scholar]
- Liu P., Feldman H. S., Covino B. M., Giasi R., Covino B. G. Acute cardiovascular toxicity of intravenous amide local anesthetics in anesthetized ventilated dogs. Anesth Analg. 1982 Apr;61(4):317–322. [PubMed] [Google Scholar]
- Luduena F. P., Bogado E. F., Tullar B. F. Optical isomers of mepivacaine and bupivacaine. Arch Int Pharmacodyn Ther. 1972 Dec;200(2):359–369. [PubMed] [Google Scholar]
- Moller R. A., Covino B. G. Cardiac electrophysiologic effects of lidocaine and bupivacaine. Anesth Analg. 1988 Feb;67(2):107–114. [PubMed] [Google Scholar]
- Nath S., Häggmark S., Johansson G., Reiz S. Differential depressant and electrophysiologic cardiotoxicity of local anesthetics: an experimental study with special reference to lidocaine and bupivacaine. Anesth Analg. 1986 Dec;65(12):1263–1270. [PubMed] [Google Scholar]
- Rosen M. A., Thigpen J. W., Shnider S. M., Foutz S. E., Levinson G., Koike M. Bupivacaine-induced cardiotoxicity in hypoxic and acidotic sheep. Anesth Analg. 1985 Nov;64(11):1089–1096. [PubMed] [Google Scholar]
- Thomas R. D., Behbehani M. M., Coyle D. E., Denson D. D. Cardiovascular toxicity of local anesthetics: an alternative hypothesis. Anesth Analg. 1986 May;65(5):444–450. [PubMed] [Google Scholar]
- Varro A., Nakaya Y., Elharrar V., Surawicz B. Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):178–185. doi: 10.1097/00005344-198601000-00026. [DOI] [PubMed] [Google Scholar]